Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
about
Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureusAntibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections.Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) studyDuration of Colonization and Determinants of Earlier Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.Antibacterial properties of the CFTR potentiator ivacaftor.Nonracemic Antifolates Stereoselectively Recruit Alternate Cofactors and Overcome Resistance in S. aureus.A prospective observational cohort study in primary care practices to identify factors associated with treatment failure in Staphylococcus aureus skin and soft tissue infections.Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study.Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.Community-acquired methicillin-resistant Staphylococcus aureus: a global problem.Antibacterial Antifolates: From Development through Resistance to the Next GenerationThe rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia.Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from blood in Rio de Janeiro displaying susceptibility profiles to non-β-lactam antibiotics.MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates.Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens.Charged Propargyl-Linked Antifolates Reveal Mechanisms of Antifolate Resistance and Inhibit Trimethoprim-Resistant MRSA Strains Possessing Clinically Relevant Mutations.Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess.Management of Staphylococcus Mediated Systemic Infection by Enhancing the Resurging Activity of Co-trimoxazole in Presence of Cryptdin-2.Multidrug and mupirocin resistance in environmental methicillin-resistant Staphylococcus aureus (MRSA) collected from the homes of people diagnosed with a community-onset (CO-) MRSA infection.Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection.Is Trimethoprim-Sulfamethoxazole a Valid Alternative in the Management of Infections in Children in the Era of Community-Acquired Methicillin-Resistant Staphylococcus aureus? A Comprehensive Systematic Review.
P2860
Q24631182-01AB994C-7929-48DF-8553-40E342406E78Q34153675-20CB2CD3-DCF3-425A-A721-6060B44E71B4Q35671893-103E2BDD-ACDB-4E8D-9213-0811235D5A02Q35813352-D1B363AB-3054-4BFF-9671-5FD7E90991DDQ36479059-C65D2BC2-BF4B-4902-B595-9F079E32CE8AQ36522836-D978504A-1E5A-4409-A1F8-ECC0210C6510Q37431852-909ECB70-329B-498E-B501-3E30DD9B4A56Q37473469-69039AC1-7CF1-42A7-A6AA-1D9AEFCCDC42Q38428770-36F670D2-F933-4FA1-A12F-A0055BD8589CQ38462323-4742CE6B-F14B-4DA6-A777-0A78C5C0501DQ38879756-474DC730-8449-498B-8C45-82522147A99DQ40084729-FCF74812-A3A0-44C2-92AE-2A9C947C82F9Q40363673-FB0929C7-76A8-419C-B9F0-92D9E6CEFD85Q40414676-7FD04CD7-23E5-478E-B35A-7F5888DE3BE8Q42043760-387CF56A-7E24-4176-9290-7DB3C4813063Q42121087-A2A96376-0D6B-4F80-997D-8217BF973339Q47104755-3BBEEB15-7A2B-4324-9835-1E2E948BE56EQ48597287-F6BC0E75-E6DF-47C0-9303-BD2D4FE6E6D5Q49911970-9E4ECA45-BCFA-4E21-8C19-A16FFD2ADDADQ50094140-2FE25DC0-9010-43F2-9BBF-97CD77464B6EQ55394725-F553063E-B568-4885-A894-CCC141999FD4
P2860
Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Trimethoprim-sulfamethoxazole ...... RSA (CA-MRSA) skin infections.
@en
Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA
@nl
type
label
Trimethoprim-sulfamethoxazole ...... RSA (CA-MRSA) skin infections.
@en
Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA
@nl
prefLabel
Trimethoprim-sulfamethoxazole ...... RSA (CA-MRSA) skin infections.
@en
Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA
@nl
P2093
P1476
Trimethoprim-sulfamethoxazole ...... RSA (CA-MRSA) skin infections.
@en
P2093
Christine U Oramasionwu
Christopher R Frei
James S Lewis
Jonathan M Hunter
Kenneth A Lawson
Monica L Miller
Robert L Talbert
P304
P356
10.3122/JABFM.2010.06.090270
P577
2010-11-01T00:00:00Z